nelfinavir has been researched along with 2019 Novel Coronavirus Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghasemlou, A; Sefidbakht, Y; Uskoković, V | 1 |
| Du, F; Feng, XL; Ge, G; Gong, L; Han, JB; Ji, J; Jiang, X; Li, C; Ling, Y; Lu, X; Peng, C; Shen, J; Shi, D; Song, TZ; Tian, RR; Wang, P; Wang, Z; Wu, C; Wu, J; Wu, N; Xu, Y; Xu, Z; Yang, J; Yao, H; Zang, Y; Zhang, J; Zhang, Y; Zheng, M; Zheng, YT; Zhu, M; Zhu, W | 1 |
| Cook, SE; Huang, V; Murphy, BG; Olsen, M; Pedersen, N | 1 |
| Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA | 1 |
| Aas, PA; Afset, JE; Biza, S; Bjørås, M; Erlandsen, SE; Fenstad, MH; Hagen, L; Ianevski, A; Kainov, DE; Landsem, VM; Lysvand, H; Løseth, K; Malmring, JF; Nordbø, SA; Oksenych, V; Pettersen, CH; Reisberg, T; Tenson, T; Yao, R; Zusinaite, E | 1 |
| Hirano, Y; Komatsu, TS; Koyama, YM; Morimoto, G; Ohno, Y; Okimoto, N; Taiji, M | 1 |
| Beberok, A; Boryczka, S; Marciniec, K; Pęcak, P; Wrześniok, D | 1 |
| Hussain, W; Kousar, K; Majeed, A; Rasool, N; Yasmin, F | 1 |
| Bakowski, MA; Beutler, N; Burton, DR; Chatterjee, AK; Chen, E; Chi, V; Das, S; Fuller, M; Garcia, E; Ghosh, P; Gupta, AK; Huang, E; Hull, MV; Joseph, SB; Kirkpatrick, MG; Kuo, P; McNamara, CW; Nguyen, TH; Pan, K; Parren, M; Ricketts, J; Riva, L; Roberts, AJ; Rogers, TF; Sahoo, D; Schultz, PG; Shaabani, N; Teijaro, JR; Vargas, N; Wolff, KC; Woods, AK; Yang, L | 1 |
| Bartolini, D; Cruciani, G; Galli, F; Gioiello, A; Pistilli, A; Rende, M; Stabile, AM; Vacca, C | 1 |
1 review(s) available for nelfinavir and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles | 2020 |
1 trial(s) available for nelfinavir and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2.
Topics: Animals; Antiviral Agents; China; COVID-19; Female; HIV Infections; Humans; Macaca mulatta; Nelfinavir; Pregnancy; Prospective Studies; SARS-CoV-2 | 2023 |
8 other study(ies) available for nelfinavir and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Exploration of potential inhibitors for SARS-CoV-2 Mpro considering its mutants via structure-based drug design, molecular docking, MD simulations, MM/PBSA, and DFT calculations.
Topics: COVID-19; Density Functional Theory; Drug Design; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Nelfinavir; Protease Inhibitors; SARS-CoV-2 | 2023 |
Perspectives: potential therapeutic options for SARS-CoV-2 patients based on feline infectious peritonitis strategies: central nervous system invasion and drug coverage.
Topics: Adenosine Triphosphate; Amodiaquine; Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Betacoronavirus; Cats; Central Nervous System; Coronavirus Infections; Coronavirus, Feline; COVID-19; COVID-19 Drug Treatment; Feline Infectious Peritonitis; Humans; Nelfinavir; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; Pyrrolidines; SARS-CoV-2; Sulfonic Acids | 2020 |
Potential Antiviral Options against SARS-CoV-2 Infection.
Topics: Amodiaquine; Animals; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Line, Tumor; Chlorocebus aethiops; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; Drug Therapy, Combination; Emetine; HEK293 Cells; Homoharringtonine; HT29 Cells; Humans; Immune Sera; Immunization, Passive; Indoles; Nelfinavir; Neutralization Tests; Pandemics; Pneumonia, Viral; Pyrans; Pyrroles; SARS-CoV-2; Vero Cells | 2020 |
Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation.
Topics: Betacoronavirus; Binding Sites; Biophysical Phenomena; Catalytic Domain; Computational Biology; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Darunavir; Drug Repositioning; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Molecular Dynamics Simulation; Nelfinavir; Pandemics; Pneumonia, Viral; Ritonavir; Saquinavir; SARS-CoV-2; Viral Nonstructural Proteins | 2020 |
Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis.
Topics: Antiviral Agents; Binding Sites; Chloroquine; Ciprofloxacin; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Moxifloxacin; Nelfinavir; Protein Binding; SARS-CoV-2 | 2020 |
Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations.
Topics: Adenosine Monophosphate; Alanine; Antimetabolites; Antiviral Agents; China; COVID-19; COVID-19 Drug Treatment; Dioxolanes; Fluoroquinolones; Humans; Methyltransferases; Molecular Docking Simulation; Nelfinavir; Phytochemicals; Piperazines; Protein Conformation; RNA Helicases; SARS-CoV-2; Topoisomerase II Inhibitors; Viral Nonstructural Proteins | 2020 |
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.
Topics: Animals; Antiviral Agents; Cell Line; COVID-19; COVID-19 Drug Treatment; Cytidine; Databases, Pharmaceutical; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxylamines; Mesocricetus; Nelfinavir; Pandemics; SARS-CoV-2; Virus Replication | 2021 |
Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caspase 9; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Cytopathogenic Effect, Viral; Endoplasmic Reticulum Stress; Humans; MAP Kinase Signaling System; Models, Biological; Nelfinavir; NF-kappa B; SARS-CoV-2; Unfolded Protein Response; Vero Cells | 2022 |